Molecular fingerprinting catches responders to therapeutic agents

High-dimensional -omics profiling predicts responses to therapeutic agents in breast cancer cell lines that can be effectively applied to patient selection in clinical trials.

Detalles Bibliográficos
Autores principales: Malik, Simeen, Tan, Patrick, Ng, Pauline C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056435/
https://www.ncbi.nlm.nih.gov/pubmed/24176101
http://dx.doi.org/10.1186/gb-2013-14-10-135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056435/
https://www.ncbi.nlm.nih.gov/pubmed/24176101
http://dx.doi.org/10.1186/gb-2013-14-10-135

Ejemplares similares